Davis J. E. 4
4 · QUEST DIAGNOSTICS INC · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Quest Diagnostics CEO Davis Receives 51,652-Share Award
What Happened
Davis J. E., CEO, President and Director of Quest Diagnostics (DGX), was issued 51,652 shares on 2026-03-04 in settlement of a performance stock award (acquisition code A) valued at $10,581,429 (51,652 × $204.86). On the same date 26,414 shares were surrendered back to the issuer to satisfy tax withholding obligations (disposition code F) totaling $5,411,172 (26,414 × $204.86).
Key Details
- Transaction dates: 2026-03-04 (reported on Form 4 filed 2026-03-06). Filing appears timely.
- Award: 51,652 shares @ $204.86 each = $10,581,429 (code A).
- Tax withholding/Disposition: 26,414 shares @ $204.86 each = $5,411,172 (code F).
- Footnotes: F1 — stock issued in settlement of a performance stock award in accordance with Rule 16b-3(d). F2 — shares disposed to issuer solely to cover tax withholding from the award.
- Shares owned after the transaction: not disclosed in the provided filing.
Context
This was a stock award settlement (not an open-market purchase or sale). The surrender of shares to the issuer to cover taxes is a routine cashless/withholding transaction and does not necessarily indicate a change in the insider’s view of the company.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-04$204.86/sh+51,652$10,581,429→ 168,837 total - Tax Payment
Common Stock
[F2]2026-03-04$204.86/sh−26,414$5,411,172→ 142,423 total
Footnotes (2)
- [F1]Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
- [F2]Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.